Heartflow, Inc.HTFLEarnings & Financial Report
HeartFlow, Inc. develops non-invasive cardiovascular diagnostic solutions for global healthcare providers. Its core product uses CT scan data to build 3D coronary artery models, assess blood flow to detect blockages, and support clinicians in making personalized heart disease treatment decisions without invasive procedures.
Revenue
$43.4M
Gross Profit
$32.8M
Operating Profit
$-13.7M
Net Profit
$-9.2M
Gross Margin
75.5%
Operating Margin
-31.6%
Net Margin
-21.2%
YoY Growth
N/A
EPS
$-1.46
Heartflow, Inc. Q2 FY2025 Financial Summary
Heartflow, Inc. reported revenue of $43.4M for Q2 FY2025, with a net profit of $-9.2M (-21.2% margin). Cost of goods sold was $10.6M, operating expenses totaled $46.5M.
Key Financial Metrics
| Total Revenue | $43.4M |
|---|---|
| Net Profit | $-9.2M |
| Gross Margin | 75.5% |
| Operating Margin | -31.6% |
| Report Period | Q2 FY2025 |
Heartflow, Inc. Quarterly Revenue & Net Profit History
Heartflow, Inc. results over the last 2 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q3 FY2025 | $46.3M | — | $-50.9M | -109.9% |
| Q2 FY2025 | $43.4M | — | $-9.2M | -21.2% |
Income Statement
| Q2 2025 | Q3 2025 | |
|---|---|---|
| Revenue | $43.4M | $46.3M |
| YoY Growth | N/A | N/A |
Balance Sheet
| Q2 2025 | Q3 2025 | |
|---|---|---|
| Assets | $159.4M | $364.4M |
| Liabilities | $285.6M | $109.8M |
| Equity | $-894.8M | $254.6M |
Cash Flow
| Q2 2025 | Q3 2025 | |
|---|---|---|
| Operating CF | $-40.5M | $-3.0M |